📢 ECP-MPA Webinar Series 2025! 📢

đź—“ 19 August 2025 (Tuesday)
⏰ 8:30 PM
đź“Ť Zoom Platform
Speaker:
President of MPA
Dr. Mohd Fadzli Mohamad Isa
Topic:
Navigating Novel Psychoactive Substances (NPS) in Clinical Practice
Overview:
The rise of Novel Psychoactive Substances (NPS)—including synthetic cannabinoids, cathinones, and hallucinogens—presents new challenges for mental health professionals. Often delivered via vaping and undetectable on standard urine screens, NPS can lead to complex psychiatric and medical presentations.
This webinar provides practical guidance for psychiatrists, addiction specialists, and mental health clinicians in recognizing, assessing, and managing NPS-related cases.
Key Topics:
  • NPS \& Vaping: Delivery methods, concealment tactics, and clinical clues.
  • When to Suspect NPS Use: Red flags and atypical psychiatric symptoms.
  • Clinical Presentation \& Risks: From psychosis to systemic toxicity.
  • Referral Guidelines: When to involve emergency or toxicology services.
  • Diagnostic Uncertainty: Managing cases with negative toxicology screens.
  • Management Strategies: Acute care, harm reduction, and patient engagement.

Learning Objectives:

  • Identify signs and complications of NPS use.
  • Approach NPS-related presentations systematically.
  • Navigate limitations of standard toxicology tests.
  • Enhance collaboration with medical and toxicology teams.
  • Apply harm reduction and long-term engagement strategies.

Limited to **100 participants.**

*For those who would like to purchase a ticket, please visit this link. MPA is no longer accepting FPX, online transfer transactions to the MPA bank account.*
***ECP Webinar Registration Fee (Non-MPA members only) – RM30.00***

Or click the link